The Oncosearch | Oncotarget

[Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration Research Paper

Laurence Booth, Jane L. Roberts, Rumeesa Rais, John Kirkwood, Francesca Avogadri-Connors, Richard E. Cutler Jr., Alshad S. Lalani, Andrew Poklepovic, Paul Dent

Published Dec 26, 2017 · Vol. 9, No. 5 · pp. 6062-6074

New cGMP analogues restrain proliferation and migration of melanoma cells Research Paper

Eleonora Vighi, Andreas Rentsch, Philipp Henning, Antonella Comitato, Dorit Hoffmann, Daniela Bertinetti, Evelina Bertolotti, Frank Schwede, Friedrich W. Herberg, Hans-Gottfried Genieser, Valeria Marigo

Published Dec 25, 2017 · Vol. 9, No. 4 · pp. 5301-5320

Distinct histone modifications denote early stress-induced drug tolerance in cancer Priority Research Paper

Abdullah Al Emran, Diego M. Marzese, Dinoop Ravindran Menon, Mitchell S. Stark, Joachim Torrano, Heinz Hammerlindl, Gao Zhang, Patricia Brafford, Matthew P. Salomon, Nellie Nelson, Sabrina Hammerlindl, Deepesh Gupta, Gordon B. Mills, Yiling Lu, Richard A. Sturm, Keith Flaherty, Dave S. B. Hoon, Brian Gabrielli, Meenhard Herlyn, Helmut Schaider

Published Dec 24, 2017 · Vol. 9, No. 9 · pp. 8206-8222

CKS1 expression in melanocytic nevi and melanoma Research Paper

Anna A. BroÅ¼yna, Andrew Aplin, Cynthia Cohen, Grant Carlson, Andrew Joseph Page, Michael Murphy, Andrzej T. Slominski, J. Andrew Carlson

Published Dec 23, 2017 · Vol. 9, No. 3 · pp. 4173-4187

Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF^V600E-mutant melanoma Research Paper

Antoneicka L. Harris, Samantha E. Lee, Louis K. Dawson, Laura A. Marlow, Brandy H. Edenfield, William F. Durham, Thomas J. Flotte, Michael Thompson, Daniel L. Small, Aidan J. Synnott, Svetomir N. Markovic, John A. Copland

Published Dec 23, 2017 · Vol. 9, No. 13 · pp. 10905-10919

Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo Research Paper

Ho-Chung Chen, Jairo Sierra, Lumeng Jenny Yu, Robert Cerchio Jr., Brian A. Wall, James Goydos, Suzie Chen

Published Dec 23, 2017 · Vol. 9, No. 5 · pp. 5861-5875

Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness Research Paper

Allison L. Isola, Kevinn Eddy, Krzysztof Zembrzuski, James S. Goydos, Suzie Chen

Published Dec 19, 2017 · Vol. 9, No. 1 · pp. 1187-1199

The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth Research Paper

Kimberley Hanson, Stephen D. Robinson, Karamallah Al-Yousuf, Adam E. Hendry, Darren W. Sexton, Victoria Sherwood, Grant N. Wheeler

Published Dec 17, 2017 · Vol. 9, No. 3 · pp. 3815-3829

Synthetic analysis of associations between IL-10 polymorphisms and skin cancer risk Research Paper

Hongbo Zhao, Jiaoli Yang, Zhenzhen Yu, Hui Shen, Xinlin Huang, Mi Zhang, Teng Long, Cailing A, Wenhui Wang

Published Dec 17, 2017 · Vol. 9, No. 6 · pp. 6728-6736

An integrated approach identifies new oncotargets in melanoma Research Paper

Daniela Cecconi, Luca Dalle Carbonare, Antonio Mori, Samuele Cheri, Michela Deiana, Jessica Brandi, Vincenzo Degaetano, Valentina Masiero, Giulio Innamorati, Monica Mottes, Giovanni Malerba, Maria Teresa Valenti

Published Dec 15, 2017 · Vol. 9, No. 14 · pp. 11489-11502

Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis Research Paper

Kuan-Fu Ding, Emanuel F. Petricoin, Darren Finlay, Hongwei Yin, William P.D. Hendricks, Chris Sereduk, Jeffrey Kiefer, Aleksandar Sekulic, Patricia M. LoRusso, Kristiina Vuori, Jeffrey M. Trent, Nicholas J. Schork

Published Dec 15, 2017 · Vol. 9, No. 4 · pp. 5044-5057

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma Research Paper

Renier Heijkants, Karen Willekens, Mark Schoonderwoerd, Amina Teunisse, Maaike Nieveen, Enrico Radaelli, Luuk Hawinkels, Jean-Christophe Marine, Aart Jochemsen

Published Dec 15, 2017 · Vol. 9, No. 5 · pp. 6174-6187

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations Research Paper

William Bruno, Claudia Martinuzzi, Bruna Dalmasso, Virginia Andreotti, Lorenza Pastorino, Francesco Cabiddu, Marina Gualco, Francesco Spagnolo, Alberto Ballestrero, Paola Queirolo, Federica Grillo, Luca Mastracci, Paola Ghiorzo

Published Dec 14, 2017 · Vol. 9, No. 5 · pp. 5691-5702

Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models Research Paper

Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, Qinghong Han, Yuying Tan, Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Takashi Murakami, Bartosz Chmielowski, Scott D. Nelson, Tara A. Russell, Sarah M. Dry, Yunfeng Li5, Michiaki Unno, Fritz C. Eilber, Robert M. Hoffman

Published Dec 12, 2017 · Vol. 9, No. 1 · pp. 915-923

Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signaling and malignant features in vitro and in vivo Research Paper

Marta SesÃ©, Pedro Fuentes, Anna Esteve-Codina, Eva BÃ©jar, Kimberley McGrail, George Thomas, Trond Aasen, Santiago RamÃ³n y Cajal

Published Dec 12, 2017 · Vol. 8, No. 70 · pp. 114856-114876

Frizzled-10 and cancer progression: Is it a new prognostic marker? Research Paper

Maria Principia Scavo, Livia Fucci, Lucia Caldarola, Anita Mangia, Amalia Azzariti, Giovanni Simone, Giampietro Gasparini, Silke Krol

Published Dec 12, 2017 · Vol. 9, No. 1 · pp. 824-830

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib Research Paper

Simona Caporali, Ester Alvino, Pedro Miguel Lacal, Federica Ruffini, Lauretta Levati, Laura Bonmassar, Alessandro Scoppola, Paolo Marchetti, Simona Mastroeni, Gian Carlo Antonini Cappellini, Stefania Dâ€™Atri

Published Dec 9, 2017 · Vol. 8, No. 69 · pp. 113472-113493

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting Research Paper

Annacarmen Petrizzo, Angela Mauriello, Antonio Luciano, Domenica Rea, Antonio Barbieri, Claudio Arra, Piera Maiolino, Marialina Tornesello, Vincenzo Gigantino, Gerardo Botti, Gennaro Ciliberto, Franco M. Buonaguro, Maria Tagliamonte, Luigi Buonaguro

Published Dec 8, 2017 · Vol. 9, No. 3 · pp. 3576-3589

CDC5L drives FAH expression to promote metabolic reprogramming in melanoma Research Paper

Zhichao Gu, Huafeng Zhang, Yong Li, Susu Shen, Xiaonan Yin, Wei Zhang, Ruimin Cheng, Yong Zhang, Xiaoyan Zhang, Hui Chen, Bo Huang, Yuchun Cao

Published Dec 7, 2017 · Vol. 8, No. 69 · pp. 114328-114343

What is changing in the adjuvant treatment of melanoma? Editorial

Paolo A. Ascierto, Giuseppe Palmieri, Helen Gogas

Published Dec 6, 2017 · Vol. 8, No. 67 · pp. 110735-110736

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

[Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration Research Paper

New cGMP analogues restrain proliferation and migration of melanoma cells Research Paper

Distinct histone modifications denote early stress-induced drug tolerance in cancer Priority Research Paper

CKS1 expression in melanocytic nevi and melanoma Research Paper

Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF^V600E-mutant melanoma Research Paper

Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo Research Paper

Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness Research Paper

The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth Research Paper

Synthetic analysis of associations between IL-10 polymorphisms and skin cancer risk Research Paper

An integrated approach identifies new oncotargets in melanoma Research Paper

Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis Research Paper

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma Research Paper

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations Research Paper

Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models Research Paper

Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signaling and malignant features in vitro and in vivo Research Paper

Frizzled-10 and cancer progression: Is it a new prognostic marker? Research Paper

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib Research Paper

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting Research Paper

CDC5L drives FAH expression to promote metabolic reprogramming in melanoma Research Paper

What is changing in the adjuvant treatment of melanoma? Editorial

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

[Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration Research Paper

New cGMP analogues restrain proliferation and migration of melanoma cells Research Paper

Distinct histone modifications denote early stress-induced drug tolerance in cancer Priority Research Paper

CKS1 expression in melanocytic nevi and melanoma Research Paper

Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAFV600E-mutant melanoma Research Paper

Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo Research Paper

Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness Research Paper

The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth Research Paper

Synthetic analysis of associations between IL-10 polymorphisms and skin cancer risk Research Paper

An integrated approach identifies new oncotargets in melanoma Research Paper

Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis Research Paper

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma Research Paper

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations Research Paper

Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models Research Paper

Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signaling and malignant features in vitro and in vivo Research Paper

Frizzled-10 and cancer progression: Is it a new prognostic marker? Research Paper

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib Research Paper

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting Research Paper

CDC5L drives FAH expression to promote metabolic reprogramming in melanoma Research Paper

What is changing in the adjuvant treatment of melanoma? Editorial

Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF^V600E-mutant melanoma Research Paper